Clinical research hints at a nuanced picture: interestingly, one trial with a GLP-1 analog (ROSE-010) noted that low doses actually accelerated colonic transit at 48 hours, possibly helping constipation, while higher doses mainly delayed stomach empty
In contrast, compounded semaglutide is not FDA-approved and can differ in quality or consistency
The Neolithic builders of Stonehenge were inspired by "auditory illusions" when they drew up blueprints for the ancient monument, a researcher claims
Tirzepatide addresses vascular ED at its root by reducing body fat, improving insulin sensitivity, lowering inflammatory markers, and improving lipid profiles
Moreover, scientists examine its cardioprotective properties in controlled study environments
Fast-acting energy and focus in ~20 minutes